- Home
- SVRA vs XRX Comparison
SVRA vs XRX Comparison
Compare SVRA & XRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- XRX
- Stock Information
- Founded
- SVRA 2007
- XRX 1906
- Country
- SVRA United States
- XRX United States
- Employees
- SVRA N/A
- XRX N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- XRX Computer peripheral equipment
- Sector
- SVRA Health Care
- XRX Technology
- Exchange
- SVRA Nasdaq
- XRX Nasdaq
- Market Cap
- SVRA 527.2M
- XRX 481.9M
- IPO Year
- SVRA N/A
- XRX N/A
- Fundamental
- Price
- SVRA $3.61
- XRX $3.63
- Analyst Decision
- SVRA Buy
- XRX Sell
- Analyst Count
- SVRA 8
- XRX 3
- Target Price
- SVRA $6.63
- XRX $6.83
- AVG Volume (30 Days)
- SVRA 1.7M
- XRX 3.9M
- Earning Date
- SVRA 11-11-2025
- XRX 10-28-2025
- Dividend Yield
- SVRA N/A
- XRX 2.75%
- EPS Growth
- SVRA N/A
- XRX N/A
- EPS
- SVRA N/A
- XRX N/A
- Revenue
- SVRA N/A
- XRX $6,174,000,000.00
- Revenue This Year
- SVRA N/A
- XRX $9.19
- Revenue Next Year
- SVRA N/A
- XRX $10.35
- P/E Ratio
- SVRA N/A
- XRX N/A
- Revenue Growth
- SVRA N/A
- XRX N/A
- 52 Week Low
- SVRA $1.89
- XRX $3.45
- 52 Week High
- SVRA $4.70
- XRX $11.29
- Technical
- Relative Strength Index (RSI)
- SVRA 65.57
- XRX 36.89
- Support Level
- SVRA $3.70
- XRX $3.75
- Resistance Level
- SVRA $3.92
- XRX $3.77
- Average True Range (ATR)
- SVRA 0.19
- XRX 0.16
- MACD
- SVRA -0.01
- XRX 0.02
- Stochastic Oscillator
- SVRA 59.10
- XRX 9.59
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About XRX Xerox Holdings Corporation
Xerox Holdings Corp is an original equipment manufacturing and software company. Xerox operates in one segment--design, development, and sale of printing technology and related solutions--while deriving 60% of its revenue from the U.S. and 40% from international markets. The company is an OEM of multifunction printers, or MFPs (printers that can print, copy, and scan), focusing on large enterprise markets. Apart from equipment, the company provides post-sales services like managed print services help to bring smart servicing and efficiencies to how employers use their print/copy equipment. Xerox is attempting to enter new markets like digital print packaging solutions and printed electronics.